Heart failure and atrial fibrillation are 2 common cardiovascular disorders that frequently
complicate one another and exert a significant detrimental effect on cardiovascular health …

Background: Despite the publication of several randomized clinical trials comparing catheter
ablation (CA) with medical therapy (MT) in patients with atrial fibrillation (AF), the superiority …

Background: In patients with heart failure and atrial fibrillation (AF), several clinical trials
have reported improved outcomes, including freedom from AF recurrence, quality of life, and …

The Japanese Circulation Society (JCS) published the “Guidelines for Pharmacological
Treatment of Arrhythmia” in 2004, and a revised edition was published in 2009. 1 Both …

Aim To investigate the characteristics long-term prognostic implications (up to∼ 2.2 years) of
atrial fibrillation (AF) compared to sinus rhythm (SR), between acute and chronic heart …

Although patients with heart failure with preserved ejection fraction (HFpEF)(left ventricular
ejection fraction≥ 50%) comprise nearly half of those with chronic heart failure, evidence …

In contrast to the wealth of proven therapies for heart failure with reduced ejection fraction
(HFrEF), therapeutic efforts in the past have failed to improve outcomes in heart failure with …

In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based
safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007 …

Background Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in
clinical practice. The aim of this review was to evaluate the progress made in the …

The development of pulmonary hypertension (PH) is common and has adverse prognostic
implications in patients with heart failure due to left heart disease (LHD), and thus far, there …